Patient-friendly summary
If you read nothing else
Bottom line
CBT and ACT appear to produce modest, statistically significant reductions in depression and smaller reductions in anxiety in fibromyalgia, supporting their use within integrated, multicomponent care rather than as standalone cures.
Moderate evidencePublished
Evidence hierarchy
Study participants
Adults with fibromyalgia confirmed by a rheumatologist (American College of Rheumatology criteria); samples were predominantly women and demographically homogenous
Study Summary
This systematic review and meta-analysis pooled 17 randomized clinical trials (1,499 adults with rheumatologist-confirmed fibromyalgia) to examine whether cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT) reduce co-occurring depression and anxiety. Thirteen trials used CBT and four used ACT, with interventions averaging about 10 sessions of roughly 95 minutes each. Pooled analysis found a statistically significant but modest-to-moderate benefit for depression (standardized mean difference −0.31, 95% CI −0.47 to −0.15) and a smaller but still significant effect for anxiety (SMD −0.15, 95% CI −0.29 to −0.02). The authors conclude both approaches may be reliably incorporated into integrated, multicomponent fibromyalgia care, while noting most included trials had unclear risk of bias.
Key Findings
| Finding | Detail | Impact |
|---|---|---|
| CBT and ACT modestly reduced depression in fibromyalgia | The pooled effect of CBT/ACT interventions on depressive symptoms at post-test was a standardized mean difference of −0.31 (95% CI −0.47 to −0.15; Z = 3.72, p = 0.0002), a statistically significant but modest-to-moderate effect. Individual effect sizes were significant in 3 studies that used a passive (waitlist/no-treatment) control. | High |
| Effects on anxiety were significant but weaker | The pooled effect on anxiety severity was a standardized mean difference of −0.15 (95% CI −0.29 to −0.02; Z = 2.18, p = 0.03), described by the authors as statistically significant but weaker than the depression effect. Substantial individual improvement was seen in one study comparing CBT with an educational program. | Medium |
| CBT trials greatly outnumbered ACT trials | Of the 17 included studies, 13 applied CBT protocols and only 4 applied ACT. The authors attribute this imbalance to CBT's longer tradition and note that ACT requires further exploration in fibromyalgia patients with comorbid emotional disorders. | Medium |
| Most evidence came from trials with unclear risk of bias | The majority of included studies had an unclear overall risk of bias. 'Selective reporting' had the lowest risk of bias, while 'incomplete outcome data' had the highest, reflecting increased attrition in psychological-intervention trials. Funnel plot inspection of depression scores suggested a reduced likelihood of publication bias. | Medium |
| Narrowly focused interventions (e.g., sleep) helped anxiety | The authors observed that interventions with a narrower focus, such as reducing sleep problems, appeared particularly useful for treating anxiety symptoms, consistent with prior evidence that CBT for insomnia may improve general wellbeing and mental health in fibromyalgia. | Low |
The pooled effect of CBT/ACT interventions on depressive symptoms at post-test was a standardized mean difference of −0.31 (95% CI −0.47 to −0.15; Z = 3.72, p = 0.0002), a statistically significant but modest-to-moderate effect. Individual effect sizes were significant in 3 studies that used a passive (waitlist/no-treatment) control.
The pooled effect on anxiety severity was a standardized mean difference of −0.15 (95% CI −0.29 to −0.02; Z = 2.18, p = 0.03), described by the authors as statistically significant but weaker than the depression effect. Substantial individual improvement was seen in one study comparing CBT with an educational program.
Of the 17 included studies, 13 applied CBT protocols and only 4 applied ACT. The authors attribute this imbalance to CBT's longer tradition and note that ACT requires further exploration in fibromyalgia patients with comorbid emotional disorders.
The majority of included studies had an unclear overall risk of bias. 'Selective reporting' had the lowest risk of bias, while 'incomplete outcome data' had the highest, reflecting increased attrition in psychological-intervention trials. Funnel plot inspection of depression scores suggested a reduced likelihood of publication bias.
The authors observed that interventions with a narrower focus, such as reducing sleep problems, appeared particularly useful for treating anxiety symptoms, consistent with prior evidence that CBT for insomnia may improve general wellbeing and mental health in fibromyalgia.
Strengths
- Followed PRISMA 2009 and Cochrane methodology with a pre-registered PROSPERO protocol (CRD42022354119)
- Included only randomized clinical trials with control groups and rheumatologist-confirmed fibromyalgia diagnoses
- Substantial pooled sample of 1,499 participants across 17 trials
- Independent dual screening and risk-of-bias assessment with third-reviewer arbitration
- Funnel plot inspection suggested low likelihood of publication bias for the depression outcome
- Low heterogeneity for the anxiety analysis (I2 = 11%)
Limitations
- Most included studies had an unclear overall risk of bias, and 'incomplete outcome data' (attrition) was a notable weakness
- Homogenous sample characteristics limit generalizability to the broader fibromyalgia population
- Change processes such as reduction in pain catastrophizing (CBT) or increased pain acceptance (ACT) were not analyzed, as few studies reported them
- Multimodal/complex interventions combining psychotherapy with medication and physical therapy were excluded
- Far fewer ACT trials (4) than CBT trials (13), limiting conclusions about ACT specifically
- Considerable variability among depression outcome reports (I2 = 42%)
Key Takeaways for Patients
What This Means for You
- 01Talking therapies such as cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT) may modestly ease the depression and anxiety that often come with fibromyalgia.
- 02These therapies are meant to work alongside (not replace) standard medical treatment as part of a combined care plan.
- 03The benefit for depression was larger and more consistent than the benefit for anxiety, which was smaller though still measurable.
- 04Most studies used about 10 sessions averaging roughly an hour and a half, delivered individually or in groups and sometimes by phone or online.
- 05Because many of the underlying studies had uncertain quality, these findings are encouraging rather than definitive.
Read the Full Paper
Access the complete peer-reviewed study from Medicine and Pharmacy Reports (Med Pharm Rep)
View Full Study